L-arginine	l-arginine	O	O	O	O
transport	transport	O	O	O	O
in	in	O	O	O	O
humans	humans	O	O	O	O
with	with	O	O	O	O
cortisol-induced	cortisol-induced	O	O	O	O
hypertension	hypertension	O	DISEASE	OTHERS	I
.	.	O	O	O	O

A	a	O	O	O	O
deficient	deficient	O	O	O	O
L-arginine-nitric	l-arginine-nitric	O	O	O	O
oxide	oxide	O	O	O	O
system	system	O	O	O	O
is	is	O	O	O	O
implicated	implicated	O	O	O	O
in	in	O	O	O	O
cortisol-induced	cortisol-induced	O	O	O	O
hypertension	hypertension	O	DISEASE	OTHERS	I
.	.	O	O	O	O

We	we	O	O	O	O
investigate	investigate	O	O	O	O
whether	whether	O	O	O	O
abnormalities	abnormalities	O	O	O	O
in	in	O	O	O	O
L-arginine	l-arginine	O	O	O	O
uptake	uptake	O	O	O	O
contribute	contribute	O	O	O	O
to	to	O	O	O	O
this	this	O	O	O	O
deficiency	deficiency	O	O	O	O
.	.	O	O	O	O

Eight	eight	O	O	O	O
healthy	healthy	O	O	O	O
men	men	O	O	O	O
were	were	O	O	O	O
recruited	recruited	O	O	O	O
.	.	O	O	O	O

Hydrocortisone	hydrocortisone	CHEMICALS	O	OTHERS	I
acetate	acetate	CHEMICALS	O	OTHERS	I
(	(	O	O	O	O
50	50	O	O	O	O
mg	mg	O	O	OTHERS	I
)	)	O	O	O	O
was	was	O	O	O	O
given	given	O	O	O	O
orally	orally	O	O	O	O
every	every	O	O	O	O
6	6	O	O	O	O
hours	hours	O	O	O	O
for	for	O	O	O	O
24	24	O	O	O	O
hours	hours	O	O	O	O
after	after	O	O	O	O
a	a	O	O	O	O
5-day	5-day	O	O	O	O
fixed-salt	fixed-salt	O	O	O	O
diet	diet	O	O	O	O
(	(	O	O	O	O
150	150	O	O	O	O
mmol/d	mmol/d	O	O	O	O
)	)	O	O	O	O
.	.	O	O	O	O

Crossover	crossover	O	O	O	O
studies	studies	O	O	O	O
were	were	O	O	O	O
performed	performed	O	O	O	O
2	2	O	O	O	O
weeks	weeks	O	O	O	O
apart	apart	O	O	O	O
.	.	O	O	O	O

Thirty	thirty	O	O	O	O
milliliters	milliliters	O	O	O	O
of	of	O	O	O	O
blood	blood	O	O	O	O
was	was	O	O	O	O
obtained	obtained	O	O	O	O
for	for	O	O	O	O
isolation	isolation	O	O	O	O
of	of	O	O	O	O
peripheral	peripheral	O	O	O	O
blood	blood	O	O	O	O
mononuclear	mononuclear	O	O	O	O
cells	cells	O	O	O	O
after	after	O	O	O	O
each	each	O	O	O	O
treatment	treatment	O	O	O	O
period	period	O	O	O	O
.	.	O	O	O	O

L-arginine	l-arginine	O	O	O	O
uptake	uptake	O	O	O	O
was	was	O	O	O	O
assessed	assessed	O	O	O	O
in	in	O	O	O	O
mononuclear	mononuclear	O	O	O	O
cells	cells	O	O	O	O
incubated	incubated	O	O	O	O
with	with	O	O	O	O
L-arginine	l-arginine	O	O	O	O
(	(	O	O	O	O
1	1	O	O	O	O
to	to	O	O	O	O
300	300	O	O	O	O
micromol/L	micromol/l	O	O	O	O
)	)	O	O	O	O
,	,	O	O	O	O
incorporating	incorporating	O	O	O	O
100	100	O	O	O	O
nmol/L	nmol/l	O	O	O	O
[3H]-l-arginine	[3h]-l-arginine	O	O	O	O
for	for	O	O	O	O
a	a	O	O	O	O
period	period	O	O	O	O
of	of	O	O	O	O
5	5	O	O	O	O
minutes	minutes	O	O	O	O
at	at	O	O	O	O
37	37	O	O	O	O
degrees	degrees	O	O	O	O
C.	c.	O	O	O	O
Forearm	forearm	O	O	O	O
[3H]-L-arginine	[3h]-l-arginine	O	O	O	O
extraction	extraction	O	O	O	O
was	was	O	O	O	O
calculated	calculated	O	O	O	O
after	after	O	O	O	O
infusion	infusion	O	O	O	O
of	of	O	O	O	O
[3H]-L-arginine	[3h]-l-arginine	O	O	O	O
into	into	O	O	O	O
the	the	O	O	O	O
brachial	brachial	O	O	O	O
artery	artery	O	O	O	O
at	at	O	O	O	O
a	a	O	O	O	O
rate	rate	O	O	O	O
of	of	O	O	O	O
100	100	O	O	O	O
nCi/min	nci/min	O	O	O	O
for	for	O	O	O	O
80	80	O	O	O	O
minutes	minutes	O	O	O	O
.	.	O	O	O	O

Deep	deep	O	O	O	O
forearm	forearm	O	O	O	O
venous	venous	O	O	O	O
samples	samples	O	O	O	O
were	were	O	O	O	O
collected	collected	O	O	O	O
for	for	O	O	O	O
determination	determination	O	O	O	O
of	of	O	O	O	O
L-arginine	l-arginine	O	O	O	O
extraction	extraction	O	O	O	O
.	.	O	O	O	O

Plasma	plasma	O	O	O	O
cortisol	cortisol	CHEMICALS	O	OTHERS	I
concentrations	concentrations	O	O	O	O
were	were	O	O	O	O
significantly	significantly	O	O	O	O
raised	raised	O	O	O	O
during	during	O	O	O	O
the	the	O	O	O	O
active	active	O	O	O	O
phase	phase	O	O	O	O
(	(	O	O	O	O
323+/-43	323+/-43	O	O	O	O
to	to	O	O	O	O
1082+/-245	1082+/-245	O	O	O	O
mmol/L	mmol/l	O	O	O	O
,	,	O	O	O	O
P<0.05	p<0.05	O	O	O	O
)	)	O	O	O	O
.	.	O	O	O	O

Systolic	systolic	O	O	O	O
blood	blood	O	O	O	O
pressure	pressure	O	O	O	O
was	was	O	O	O	O
elevated	elevated	O	O	O	O
by	by	O	O	O	O
an	an	O	O	O	O
average	average	O	O	O	O
of	of	O	O	O	O
7	7	O	O	O	O
mm	mm	O	O	OTHERS	I
Hg	hg	O	O	OTHERS	I
.	.	O	O	O	O

Neither	neither	O	O	O	O
L-arginine	l-arginine	O	O	O	O
transport	transport	O	O	O	O
into	into	O	O	O	O
mononuclear	mononuclear	O	O	O	O
cells	cells	O	O	O	O
(	(	O	O	O	O
placebo	placebo	O	O	O	O
vs	vs	O	O	O	O
active	active	O	O	O	O
,	,	O	O	O	O
26.3+/-3.6	26.3+/-3.6	O	O	O	O
vs	vs	O	O	O	O
29.0+/-2.1	29.0+/-2.1	O	O	O	O
pmol/10	pmol/10	O	O	O	O
000	000	O	O	O	O
cells	cells	O	O	O	O
per	per	O	O	O	O
5	5	O	O	O	O
minutes	minutes	O	O	O	O
,	,	O	O	O	O
respectively	respectively	O	O	O	O
,	,	O	O	O	O
at	at	O	O	O	O
an	an	O	O	O	O
l-arginine	l-arginine	O	O	O	O
concentration	concentration	O	O	O	O
of	of	O	O	O	O
300	300	O	O	O	O
micromol/L	micromol/l	O	O	O	O
)	)	O	O	O	O
nor	nor	O	O	O	O
L-arginine	l-arginine	O	O	O	O
extraction	extraction	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
forearm	forearm	O	O	O	O
(	(	O	O	O	O
at	at	O	O	O	O
80	80	O	O	O	O
minutes	minutes	O	O	O	O
,	,	O	O	O	O
placebo	placebo	O	O	O	O
vs	vs	O	O	O	O
active	active	O	O	O	O
,	,	O	O	O	O
1	1	O	O	O	O
868	868	O	O	O	O
904+/-434	904+/-434	O	O	O	O
962	962	O	O	O	O
vs	vs	O	O	O	O
2	2	O	O	O	O
013	013	O	O	O	O
910+/-770	910+/-770	O	O	O	O
619	619	O	O	O	O
disintegrations	disintegrations	O	O	O	O
per	per	O	O	O	O
minute	minute	O	O	O	O
)	)	O	O	O	O
was	was	O	O	O	O
affected	affected	O	O	O	O
by	by	O	O	O	O
cortisol	cortisol	CHEMICALS	O	OTHERS	I
treatment	treatment	O	O	O	O
;	;	O	O	O	O
ie	ie	O	O	OTHERS	I
,	,	O	O	O	O
that	that	O	O	O	O
L-arginine	l-arginine	O	O	O	O
uptake	uptake	O	O	O	O
is	is	O	O	O	O
not	not	O	O	O	O
affected	affected	O	O	O	O
by	by	O	O	O	O
short-term	short-term	O	O	O	O
cortisol	cortisol	CHEMICALS	O	OTHERS	I
treatment	treatment	O	O	O	O
.	.	O	O	O	O

We	we	O	O	O	O
conclude	conclude	O	O	O	O
that	that	O	O	O	O
cortisol-induced	cortisol-induced	O	O	O	O
increases	increases	O	O	OTHERS	I
in	in	O	O	OTHERS	I
blood	blood	O	O	OTHERS	I
pressure	pressure	O	O	OTHERS	I
are	are	O	O	O	O
not	not	O	O	O	O
associated	associated	O	O	O	O
with	with	O	O	O	O
abnormalities	abnormalities	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
l-arginine	l-arginine	O	O	O	O
transport	transport	O	O	O	O
system	system	O	O	O	O
.	.	O	O	O	O

